Objective:

To update Women's Preventive Services guidelines for cervical cancer screening, including self-collection of high-risk HPV specimens and coverage for additional testing needed to complete the screening process.

Key Findings:

• Self-collection may improve screening rates by reducing discomfort and increasing access.
• Cervical cancer screening has significantly reduced incidence and mortality rates over the past 50 years, representing a major public health achievement.
• More than half of cervical cancer diagnoses occur at advanced stages, highlighting the need for improved screening.

Interpretation:

The inclusion of self-collection aims to address disparities in cervical cancer screening and outcomes, particularly among underserved populations.

Limitations:

• Self-collection is restricted to average-risk patients only.
• Excludes patients with HIV, immunocompromised conditions, and those treated for cervical intraepithelial neoplasia grade 2 or higher in the past 20 years.
• Ongoing research is needed to determine optimal screening intervals and age for self-collection, and self-collection should only be performed with FDA-approved tests.

Conclusion:

The updated guidelines aim to enhance cervical cancer screening accessibility and effectiveness, while also addressing public health disparities in outcomes.